Income Statement

v3.8.0.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenues $ 2,500 $ 2,500 $ 7,500 $ 7,500
Operating expenses:        
Research and development expenses 1,383,863 3,589,793 6,871,028 9,130,012
General and administrative expenses 1,206,510 1,329,712 4,174,583 5,862,374
Total operating expenses 2,590,373 4,919,505 11,045,611 14,992,386
Operating loss (2,587,873) (4,917,005) (11,038,111) (14,984,886)
Other income (expense):        
Interest income 18,099 17,293 52,995 41,862
Interest expense (1,383) (240,462) (155,843) (949,375)
Change in fair value of derivative instruments 2,679,770 (538,261) (403,155) 219,014
Gain on related party settlement 458,608 458,608
Fees related to issuance of derivative liabilities, warrant inducement and other expenses (242,396) (456) (806,115) (463,798)
Total other income (expense) 2,454,090 (303,278) (1,312,118) (693,689)
Net loss $ (133,783) $ (5,220,283) $ (12,350,229) $ (15,678,575)
Net loss per share - basic (in dollars per share) $ (0.01) $ (0.59) $ (1) $ (1.96)
Net loss per share - diluted (in dollars per share) $ (0.18) $ (0.59) $ (1) $ (1.96)
Weighted average common shares outstanding - basic (in shares) 14,060,844 8,835,045 12,380,054 8,019,153
Weighted average common shares outstanding - diluted (in shares) 14,163,072 8,835,045 12,380,054 8,019,153
Comprehensive loss:        
Net loss $ (133,783) $ (5,220,283) $ (12,350,229) $ (15,678,575)
Foreign currency translation adjustment (1,005) 21 (1,560) 1,516
Comprehensive loss $ (134,788) $ (5,220,262) $ (12,351,789) $ (15,677,059)

Source